Investing

Zinc Price 2023 Year-End Review

Zinc started 2023 in a strong position, having come close to all-time highs in April 2022.

However, zinc fell in H1 amid a rout in the base metals market. While smelting and supply issues from 2022 supported the price early on, weak demand, particularly due to slower economic recovery in China, caused zinc to move from undersupplied to oversupplied by the end of the year. The vast majority of zinc is used in alloys and for galvanization.

After dropping in the first half of 2023, zinc remained largely rangebound for the rest of the year, staying below the US$2,700 per metric ton (MT) level. Read on to learn more about what factors impacted the market during the period.

How did zinc perform in 2023?

Zinc price in H1

After starting the year at US$3,002 on January 3, zinc rose quickly in the first month of the year, reaching its 2023 high of US$3,486.50 on January 26. This increase came as London Metal Exchange (LME) stockpiles of the metal reached a three decade low of under 20,000 MT, down from 80,000 MT in July 2022. Interestingly, zinc’s price was far lower than it was in 2006, when it reached a record high of US$4,442 as LME stockpiles sank to 110,000 MT.

Smelter bottlenecks in Europe helped support the zinc price, with activity low due to high energy prices.

Zinc price from January 3, 2023, to December 29, 2023.

Chart via Trading Economics.

The International Lead and Zinc Study Group (ILZSG), an intergovernmental organization of government officials and industry experts, forecast in October 2022 that zinc would face a deficit of 150,000 MT in 2023. However, by the year’s second quarter, the group had revised its expectation to a more marginal deficit of 45,000 MT.

This was brought on by a slump in China’s real estate sector. The downturn affected the broader base metals market, and lowered demand for all steel products. It was also impacted by European energy prices as they hit 18 month lows, allowing for better economic conditions and the resumption of smelting operations, increasing supply.

Falling demand and rising supply added downward pressure to the price of zinc, dropping it to US$2,248.50 on May 31 — its lowest since September 2020 and ultimately its low point for 2023.

The combination of low prices for zinc along with high mining costs caused Boliden (STO:BOL) to place its Tara zinc mine in Ireland on care and maintenance on June 13. Tara, the largest zinc mine in Europe, produced 198,000 metric tons of concentrates in 2022, and its output feeds the company’s Odda zinc smelter in Norway. The announcement of Tara’s closure caused the price of zinc to jump 5 percent on the LME that day to US$2,491.

Zinc price in H2

Despite the suspension at Boliden’s facility and small gains in the zinc price that saw it reach US$2,569 on August 1, markets were already shifting from undersupply to oversupply. Stockpiles at the LME reached 145,975 metric tons by the middle of August — doubling their mid-July stockpiles in just a month’s time — which pushed the price back down to US$2,283.50.

Some of this excess in supply came from Citigroup (NYSE:C), which purchased large quantities of zinc and cut a rent-share deal to store it at LME warehouses in Singapore. The move allowed Citigroup to capitalize on the premium for storing zinc on LME warrants and bolster its portfolio through a metals-financing strategy that wasn’t possible when supply for zinc was tighter. The group extended its position throughout Q3 and Q4 with further purchases. While Citi has been tight-lipped about the specifics of the deal, insiders told Bloomberg that Citi has accrued a position in the 40,000 MT range.

Zinc prices rebounded through the second half of August and into September to reach a Q3 high of US$2,649.50 on September 29, and remained range bound between US$2,400 and US$2,660 through Q4.

In its last update for the year released in December, the ILZSG reported that through the first 10 months of 2023, supply for zinc had outstripped demand by 295,000 MT, moving what was projected to be a deficit at the start of the year to a surplus at the end.

The continued depression in zinc prices in H2 caused further temporary closures of mining and smelting operations. Private company Almina-Minas announced it would be putting closing its Aljustrel zinc-lead operation in Southern Portugal on care and maintenance from September 24 until mid-2025 in part due to low pricing in the market. This was followed by news that Trafigura subsidiary Nyrstar (LSE:0RH8) would suspend operations at the end of November at its two zinc mines in Tennessee, US.

The price of zinc closed out 2023 at US$2,658 on December 29.

Investor takeaway

2023 was a relatively lackluster year for zinc. High interest rates, an inflationary environment and a sputtering Chinese economy provided for the perfect storm to stall demand for the metal. Meanwhile, supply remained high, causing zinc to be the second worst performing metal on the LME after nickel. However, Citigroup’s move in the middle of the year to take advantage of low prices and high supply brought a surprise factor to the market.

Temporary closures in 2024 are expected to constrain zinc supply, but it remains to be seen how prices will be affected and whether demand will pick up.

Securities Disclosure: I, Dean Belder, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

You May Also Like

Investing

2023 was a relatively lackluster year, silver largely traded on volatility between US$22 and US$25 per ounce. The white metal started 2024 with less...

Latest News

Dong’s experience, both as head of the People’s Liberation Army Navy (PLAN) as well as operational assignments in the Chinese military’s Eastern and Southern...

Investing

The US was one of the world’s top silver producers in 2023, recording output of 1,000 metric tons (MT). While that’s far below first-place...

Investing

The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription drug market. But what...

Disclaimer: GreatWallStreetPublisher.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 GreatWallStreetPublisher.com

Exit mobile version